Literature DB >> 21275466

The expression of histone demethylase JMJD1A in renal cell carcinoma.

X Guo1, M Shi, L Sun, Y Wang, Y Gui, Z Cai, X Duan.   

Abstract

BACKGROUND: Hypoxia-inducible factor 1α has been shown to play a central role in RCC tumorigenesis by acting as a transcription factor. Histone demethylase JMJD1A is an iron- and 2-oxoglutarate-dependent dioxygenase which catalyze the demethylation of mono- and dimethylated H3K9. JMJD1A can be upregulated by hypoxia via HIF-1 and associated with cancer. The expression of JMJD1A was determined in 10 kidney cancer tissue and adjacent tissue by quantitative polymerase chain reaction, western blotting and immunohistochemistry. Furthermore, the expression of JMJD1A was investigated in cell line 786-0 through adding nickle or cobalt ion to mimic hypoxic environment. The expression of JMJD1A was higher in cancer tissue than adjacent tissue, and in hypoxic environment than normal environment. In cancer tissue, the JMJD1A mainly located around blood vessels which indicated that JMJD1A is involved tumor angiogenesis.
CONCLUSION: the increased expression of JMJD1A might be associated with the progression of kidney cancer. KEYWORDS: renal cell carcinoma, histone demethylase, JMJD1A, hypoxia-inducible factor, iron.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21275466     DOI: 10.4149/neo_2011_02_153

Source DB:  PubMed          Journal:  Neoplasma        ISSN: 0028-2685            Impact factor:   2.575


  24 in total

Review 1.  Molecular mechanisms and potential functions of histone demethylases.

Authors:  Susanne Marije Kooistra; Kristian Helin
Journal:  Nat Rev Mol Cell Biol       Date:  2012-04-04       Impact factor: 94.444

2.  Retraction note to: KDM3A confers metastasis and chemoresistance in epithelial ovarian cancer.

Authors: 
Journal:  J Mol Histol       Date:  2015-12       Impact factor: 2.611

Review 3.  The role of histone demethylases in cancer therapy.

Authors:  Inga Hoffmann; Martin Roatsch; Martin L Schmitt; Luca Carlino; Martin Pippel; Wolfgang Sippl; Manfred Jung
Journal:  Mol Oncol       Date:  2012-08-07       Impact factor: 6.603

4.  TET2-dependent IL-6 induction mediated by the tumor microenvironment promotes tumor metastasis in osteosarcoma.

Authors:  Hitoshi Itoh; Tsuyoshi Kadomatsu; Hironori Tanoue; Masaki Yugami; Keishi Miyata; Motoyoshi Endo; Jun Morinaga; Eisuke Kobayashi; Takeshi Miyamoto; Ryoma Kurahashi; Kazutoyo Terada; Hiroshi Mizuta; Yuichi Oike
Journal:  Oncogene       Date:  2018-03-08       Impact factor: 9.867

5.  Proteome Analysis of Hypoxic Glioblastoma Cells Reveals Sequential Metabolic Adaptation of One-Carbon Metabolic Pathways.

Authors:  Kangling Zhang; Pei Xu; James L Sowers; Daniel F Machuca; Barsam Mirfattah; Jason Herring; Hui Tang; Yan Chen; Bing Tian; Allan R Brasier; Lawrence C Sowers
Journal:  Mol Cell Proteomics       Date:  2017-09-05       Impact factor: 5.911

6.  Nitric oxide modifies global histone methylation by inhibiting Jumonji C domain-containing demethylases.

Authors:  Jason R Hickok; Divya Vasudevan; William E Antholine; Douglas D Thomas
Journal:  J Biol Chem       Date:  2013-04-01       Impact factor: 5.157

7.  Elevated JMJD1A is a novel predictor for prognosis and a potential therapeutic target for gastric cancer.

Authors:  Haiyan Yang; Zhenguo Liu; Cuncun Yuan; Yunfei Zhao; Lei Wang; Jiong Hu; Dacheng Xie; Liwei Wang; Donghui Chen
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

Review 8.  Histone lysine demethylases as targets for anticancer therapy.

Authors:  Jonas W Højfeldt; Karl Agger; Kristian Helin
Journal:  Nat Rev Drug Discov       Date:  2013-11-15       Impact factor: 84.694

9.  Histone modifications: implications in renal cell carcinoma.

Authors:  Swathi Ramakrishnan; Leigh Ellis; Roberto Pili
Journal:  Epigenomics       Date:  2013-08       Impact factor: 4.778

10.  JMJD1A promotes tumorigenesis and forms a feedback loop with EZH2/let-7c in NSCLC cells.

Authors:  Min Zhan; Feiqiu Wen; Lijuan Liu; Zebin Chen; Hong Wei; Honghao Zhou
Journal:  Tumour Biol       Date:  2016-03-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.